Health product recall

Vyvanse Capsule (2019-08-08)

Starting date:
August 8, 2019
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-70695

Last updated: 2019-08-13

Summary

  • Product: Vyvanse 20 mg Capsule

Reason

The dissolution in the affected lot is out of specification.

Depth of distribution

Wholesalers

Affected products

Vyvanse 20 mg Capsule

DIN, NPN, DIN-HIM

DIN 02347156

Dosage form

Capsule

Strength

Lisdexamfetamine dimesylate 20 mg

Lot or serial number

AG4982B

Companies

Recalling Firm
Shire Pharma Canada ULC
22 Adelaide St West, Suite 3800
Toronto
M5H 4E3
Ontario
CANADA
Marketing Authorization Holder
Shire Pharma Canada ULC
22 Adelaide St West, Suite 3800
Toronto
M5H 4E3
Ontario
CANADA

Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: